Cargando…

Asfotase alfa has a limited effect in improving the bowed limbs in perinatal benign hypophosphatasia: A case report

Hypophosphatasia (HPP) is a rare skeletal dysplasia characterized by impaired bone mineralization, caused by loss-of-function mutations in the tissue-nonspecific alkaline phosphatase (TNSALP) gene. Enzyme replacement therapy (ERT) by administration of asfotase alfa was reported to improve the surviv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsushita, Masaki, Mishima, Kenichi, Nagata, Tadashi, Kamiya, Yasunari, Imagama, Shiro, Kitoh, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society for Pediatric Endocrinology 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783131/ https://www.ncbi.nlm.nih.gov/pubmed/33446953 http://dx.doi.org/10.1297/cpe.30.53

Ejemplares similares

A Rare Case of Perinatal Hypophosphatasia Treated With Asfotase Alfa
por: Srivastava, Priya S, et al.
Publicado: (2021)

Pathophysiology of hypophosphatasia and the potential role of asfotase alfa
por: Orimo, Hideo
Publicado: (2016)

Hearing impairment improved after treatment with asfotase alfa in a case of perinatal hypophosphatasia
por: Chida-Naomiya, Rie, et al.
Publicado: (2020)

Pharmacokinetics of Asfotase Alfa in Adult Patients With Pediatric‐Onset Hypophosphatasia
por: Pan, Wei‐Jian, et al.
Publicado: (2021)

Excellent response to asfotase alfa treatment in an adolescent patient with hypophosphatasia
por: Strandbech, Olivia Sarah, et al.
Publicado: (2021)

Effect of Asfotase Alfa in the Treatment of Hypophosphatasia- A Systematic Review
por: Jaswanthi, N, et al.
Publicado: (2023)

Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy
por: Bowden, Sasigarn A, et al.
Publicado: (2018)

Successful Asfotase Alfa Treatment in an Adult Dialysis Patient With Childhood-Onset Hypophosphatasia
por: Remde, Hanna, et al.
Publicado: (2017)

Fracture Healing in Two Adult Patients With Hypophosphatasia After Asfotase Alfa Therapy
por: Klidaras, Philostratos, et al.
Publicado: (2018)

MON-497 Adult Onset Hypophosphatasia: Before and After Treatment with Asfotase Alfa
por: Magdaleno, Angela, et al.
Publicado: (2019)

Altered Thyroid Function Tests Observed in Hypophosphatasia Patients Treated with Asfotase Alfa
por: Kato, Hajime, et al.
Publicado: (2021)

Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfa
por: Seefried, L., et al.
Publicado: (2021)

THU460 A Case Series Of Hypophosphatasia: Presentation And Response To Asfotase Alfa
por: Alsarraf, Farah, et al.
Publicado: (2023)

Predictive ability of inflammatory markers and laboratory parameters in Legg-Calvé-Perthes disease: A single-center retrospective comparative study
por: Mishima, Kenichi, et al.
Publicado: (2022)

Radiological evaluation of pseudofracture after the administration of asfotase alfa in an adult with benign prenatal hypophosphatasia: A case report
por: Kato, Hajime, et al.
Publicado: (2021)

OR13-4 Safety Profile of Asfotase Alfa Treatment of Patients with Hypophosphatasia: A Pooled Analysis
por: Whyte, Michael, et al.
Publicado: (2019)

A Japanese single-center experience of the efficacy and safety of asfotase alfa in pediatric-onset hypophosphatasia
por: Sugiyama, Yohei, et al.
Publicado: (2022)

Legg‐Calvé‐Perthes disease in a patient with Bardet‐Biedl syndrome: A case report of a novel MKKS/BBS6 mutation
por: Mishima, Kenichi, et al.
Publicado: (2020)

Physical Function and Health‐Related Quality of Life in Adults Treated With Asfotase Alfa for Pediatric‐Onset Hypophosphatasia
por: Genest, Franca, et al.
Publicado: (2020)

Effect of Asfotase Alfa on Muscle Weakness in a Japanese Adult Patient of Hypophosphatasia with Low ALP Levels
por: Koyama, Hiroyuki, et al.
Publicado: (2019)

Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study
por: Hofmann, Christine E, et al.
Publicado: (2019)

Extensive Bone Lengthening for a Patient with Linear Morphea
por: Mishima, Kenichi, et al.
Publicado: (2018)

Prognostic value of bone resorption pattern in the anterior portion of the femoral head in Legg–Calvé–Perthes disease
por: Mishima, Kenichi, et al.
Publicado: (2023)

Meclozine ameliorates bone mineralization and growth plate structure in a mouse model of X‑linked hypophosphatemia
por: Kamiya, Yasunari, et al.
Publicado: (2022)

Improvement of bone microarchitecture parameters after 12 months of treatment with asfotase alfa in adult patient with hypophosphatasia: Case report
por: Freitas, Thiago Quadrante, et al.
Publicado: (2018)

A two-year follow-up of asfotase alfa replacement in a patient with hypophosphatasia: clinical, biochemical, and radiological evaluation
por: Reis, Fernanda Salles, et al.
Publicado: (2020)

Case Report: Efficacy of Reduced Doses of Asfotase Alfa Replacement Therapy in an Infant With Hypophosphatasia Who Lacked Severe Clinical Symptoms
por: Fujisawa, Yasuko, et al.
Publicado: (2020)

Activated FGFR3 suppresses bone regeneration and bone mineralization in an ovariectomized mouse model
por: Kawashima, Itaru, et al.
Publicado: (2023)

Health-related Quality of Life in Adult Patients with Multiple Epiphyseal Dysplasia and Spondyloepiphyseal Dysplasia
por: Matsushita, Masaki, et al.
Publicado: (2021)

Acute osteomyelitis of the patella due to Pseudomonas aeruginosa in an immunocompetent child: A case report
por: Kamiya, Yasunari, et al.
Publicado: (2023)

Severe achondroplasia due to two de novo variants in the transmembrane domain of FGFR3 on the same allele: A case report
por: Nagata, Tadashi, et al.
Publicado: (2020)

Phase 1b study on the repurposing of meclizine hydrochloride for children with achondroplasia
por: Matsushita, Masaki, et al.
Publicado: (2023)

Effect of periosteal resection on longitudinal bone growth in a mouse model of achondroplasia
por: Kaneko, Shinya, et al.
Publicado: (2020)

Pharmacokinetics and safety after once and twice a day doses of meclizine hydrochloride administered to children with achondroplasia
por: Kitoh, Hiroshi, et al.
Publicado: (2020)

Odontohypophosphatasia treated with asfotase alfa enzyme replacement therapy in a toddler: a case report
por: Takagi, Mizuki, et al.
Publicado: (2020)

Marked motor function improvement in a 32-year-old woman with childhood-onset hypophosphatasia by asfotase alfa therapy: Evaluation based on standardized testing batteries used in Duchenne muscular dystrophy clinical trials
por: Nishizawa, Hitomi, et al.
Publicado: (2020)

Inconvenience and adaptation in Japanese adult achondroplasia and hypochondroplasia: A cross-sectional study
por: Ajimi, Akiko, et al.
Publicado: (2021)

Perinatal Hypophosphatasia in a Premature Infant
por: Sankaran, Deepika, et al.
Publicado: (2020)

Percutaneous pinning after prolonged skeletal traction with the hip in a flexed position for unstable slipped capital femoral epiphysis: A case series of 11 patients
por: Matsushita, Masaki, et al.
Publicado: (2017)

Differential diagnosis of perinatal hypophosphatasia: radiologic perspectives
por: Offiah, Amaka C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ngkih6lfd354hih3b7o6dvk9vc